Physician Wealth Solutions Inc. lifted its stake in Avantis Emerging Markets Equity ETF (NYSEARCA:AVEM – Free Report) by 10.0% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 55,511 shares of the company’s stock after buying an additional 5,051 shares during the quarter. Avantis Emerging Markets Equity ETF makes up about 1.6% of Physician Wealth Solutions Inc.’s investment portfolio, making the stock its 18th largest position. Physician Wealth Solutions Inc.’s holdings in Avantis Emerging Markets Equity ETF were worth $3,263,000 as of its most recent filing with the SEC.
Several other hedge funds have also recently modified their holdings of AVEM. Strategic Financial Concepts LLC lifted its holdings in shares of Avantis Emerging Markets Equity ETF by 7,223.2% in the fourth quarter. Strategic Financial Concepts LLC now owns 2,894,202 shares of the company’s stock worth $170,150,000 after buying an additional 2,854,681 shares in the last quarter. Savant Capital LLC lifted its holdings in shares of Avantis Emerging Markets Equity ETF by 7.6% in the fourth quarter. Savant Capital LLC now owns 16,567,391 shares of the company’s stock worth $973,997,000 after buying an additional 1,172,561 shares in the last quarter. Jane Street Group LLC lifted its holdings in shares of Avantis Emerging Markets Equity ETF by 380.2% in the third quarter. Jane Street Group LLC now owns 1,421,298 shares of the company’s stock worth $91,816,000 after buying an additional 1,125,300 shares in the last quarter. MML Investors Services LLC lifted its holdings in shares of Avantis Emerging Markets Equity ETF by 270.3% in the third quarter. MML Investors Services LLC now owns 941,220 shares of the company’s stock worth $60,803,000 after buying an additional 687,056 shares in the last quarter. Finally, Merit Financial Group LLC lifted its holdings in shares of Avantis Emerging Markets Equity ETF by 486.2% in the fourth quarter. Merit Financial Group LLC now owns 713,524 shares of the company’s stock worth $41,948,000 after buying an additional 591,800 shares in the last quarter.
Avantis Emerging Markets Equity ETF Stock Down 0.9 %
Avantis Emerging Markets Equity ETF stock opened at $58.70 on Tuesday. The company has a market cap of $7.35 billion, a price-to-earnings ratio of 11.90 and a beta of 0.78. The firm’s fifty day moving average is $59.59 and its 200 day moving average is $61.26. Avantis Emerging Markets Equity ETF has a 52-week low of $55.65 and a 52-week high of $66.31.
Avantis Emerging Markets Equity ETF Company Profile
The Avantis Emerging Markets Equity ETF (AVEM) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund that holds emerging-market stocks of all market capitalizations considered favorable on multiple factors. The fund seeks to provide capital appreciation.
Featured Stories
- Five stocks we like better than Avantis Emerging Markets Equity ETF
- What is the Dow Jones Industrial Average (DJIA)?
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Want to see what other hedge funds are holding AVEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantis Emerging Markets Equity ETF (NYSEARCA:AVEM – Free Report).
Receive News & Ratings for Avantis Emerging Markets Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantis Emerging Markets Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.